位置:首页 > 蛋白库 > MYO3A_MOUSE
MYO3A_MOUSE
ID   MYO3A_MOUSE             Reviewed;        1613 AA.
AC   Q8K3H5;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   03-AUG-2022, entry version 135.
DE   RecName: Full=Myosin-IIIa;
DE            EC=2.7.11.1;
GN   Name=Myo3a;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C3H/HeJ;
RX   PubMed=12032315; DOI=10.1073/pnas.102091699;
RA   Walsh T., Walsh V., Vreugde S., Hertzano R., Shahin H., Haika S., Lee M.K.,
RA   Kanaan M., King M.-C., Avraham K.B.;
RT   "From flies' eyes to our ears: mutations in a human class III myosin cause
RT   progressive nonsyndromic hearing loss DFNB30.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7518-7523(2002).
RN   [2]
RP   FUNCTION.
RX   PubMed=19287378; DOI=10.1038/ncb1851;
RA   Salles F.T., Merritt R.C. Jr., Manor U., Dougherty G.W., Sousa A.D.,
RA   Moore J.E., Yengo C.M., Dose A.C., Kachar B.;
RT   "Myosin IIIa boosts elongation of stereocilia by transporting espin 1 to
RT   the plus ends of actin filaments.";
RL   Nat. Cell Biol. 11:443-450(2009).
RN   [3]
RP   FUNCTION, DISRUPTION PHENOTYPE, INTERACTION WITH MORN4, TISSUE SPECIFICITY,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=26754646; DOI=10.1083/jcb.201509017;
RA   Lelli A., Michel V., Boutet de Monvel J., Cortese M., Bosch-Grau M.,
RA   Aghaie A., Perfettini I., Dupont T., Avan P., El-Amraoui A., Petit C.;
RT   "Class III myosins shape the auditory hair bundles by limiting microvilli
RT   and stereocilia growth.";
RL   J. Cell Biol. 212:231-244(2016).
RN   [4]
RP   INTERACTION WITH ESPN AND ESPNL.
RX   PubMed=26926603; DOI=10.1038/ncomms10833;
RA   Ebrahim S., Avenarius M.R., Grati M., Krey J.F., Windsor A.M., Sousa A.D.,
RA   Ballesteros A., Cui R., Millis B.A., Salles F.T., Baird M.A.,
RA   Davidson M.W., Jones S.M., Choi D., Dong L., Raval M.H., Yengo C.M.,
RA   Barr-Gillespie P.G., Kachar B.;
RT   "Stereocilia-staircase spacing is influenced by myosin III motors and their
RT   cargos espin-1 and espin-like.";
RL   Nat. Commun. 7:10833-10833(2016).
CC   -!- FUNCTION: Probable actin-based motor with a protein kinase activity.
CC       Probably plays a role in vision and hearing (By similarity). Required
CC       for normal cochlear hair bundle development and hearing. Plays an
CC       important role in the early steps of cochlear hair bundle
CC       morphogenesis. Influences the number and lengths of stereocilia to be
CC       produced and limits the growth of microvilli within the forming
CC       auditory hair bundles thereby contributing to the architecture of the
CC       hair bundle, including its staircase pattern (PubMed:26754646).
CC       Involved in the elongation of actin in stereocilia tips by transporting
CC       the actin regulatory factor ESPN to the plus ends of actin filaments
CC       (PubMed:19287378). {ECO:0000250|UniProtKB:Q8NEV4,
CC       ECO:0000269|PubMed:19287378, ECO:0000269|PubMed:26754646}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBUNIT: Interacts with MORN4 (PubMed:26754646). Interacts (via C-
CC       terminus) with ESPN and ESPNL (PubMed:26926603).
CC       {ECO:0000269|PubMed:26754646, ECO:0000269|PubMed:26926603}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm
CC       {ECO:0000269|PubMed:26754646}. Cell projection, filopodium tip
CC       {ECO:0000250|UniProtKB:Q8NEV4}. Cell projection, stereocilium
CC       {ECO:0000269|PubMed:26754646}. Note=Increased localization at the
CC       filodium tip seen in the presence of MORN4.
CC       {ECO:0000250|UniProtKB:Q8NEV4}.
CC   -!- TISSUE SPECIFICITY: Expressed in the cochlear hair cells (at protein
CC       level) (PubMed:26754646). Expressed in utricle hair bundles (at protein
CC       level) (PubMed:26926603). {ECO:0000269|PubMed:26754646,
CC       ECO:0000269|PubMed:26926603}.
CC   -!- DISRUPTION PHENOTYPE: MYO3A single knockout mice do not exhibit early
CC       hearing impairment whereas mice with a double knockout of MYO3A and
CC       MYO3B are profoundly deaf at 1 month of age. Cochlear hair bundles have
CC       abnormally long stereocilia and show dynamic shape defects during
CC       development. {ECO:0000269|PubMed:26754646}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the TRAFAC class
CC       myosin-kinesin ATPase superfamily. Myosin family. {ECO:0000305}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the protein kinase
CC       superfamily. STE Ser/Thr protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY101368; AAM34501.1; -; mRNA.
DR   AlphaFoldDB; Q8K3H5; -.
DR   SMR; Q8K3H5; -.
DR   STRING; 10090.ENSMUSP00000046329; -.
DR   iPTMnet; Q8K3H5; -.
DR   PhosphoSitePlus; Q8K3H5; -.
DR   PaxDb; Q8K3H5; -.
DR   PRIDE; Q8K3H5; -.
DR   ProteomicsDB; 287585; -.
DR   MGI; MGI:2183924; Myo3a.
DR   eggNOG; KOG0587; Eukaryota.
DR   eggNOG; KOG4229; Eukaryota.
DR   InParanoid; Q8K3H5; -.
DR   PhylomeDB; Q8K3H5; -.
DR   ChiTaRS; Myo3a; mouse.
DR   PRO; PR:Q8K3H5; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q8K3H5; protein.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0031941; C:filamentous actin; ISS:UniProtKB.
DR   GO; GO:0030175; C:filopodium; ISS:UniProtKB.
DR   GO; GO:0032433; C:filopodium tip; IDA:MGI.
DR   GO; GO:0016459; C:myosin complex; IEA:UniProtKB-KW.
DR   GO; GO:0001917; C:photoreceptor inner segment; IDA:MGI.
DR   GO; GO:0032426; C:stereocilium tip; IDA:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IDA:MGI.
DR   GO; GO:0043531; F:ADP binding; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0000146; F:microfilament motor activity; IDA:MGI.
DR   GO; GO:0060002; F:plus-end directed microfilament motor activity; ISS:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:MGI.
DR   GO; GO:0060088; P:auditory receptor cell stereocilium organization; IMP:MGI.
DR   GO; GO:0090103; P:cochlea morphogenesis; IMP:UniProtKB.
DR   GO; GO:0048839; P:inner ear development; IMP:MGI.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:MGI.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:MGI.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; IGI:MGI.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:MGI.
DR   GO; GO:0030832; P:regulation of actin filament length; IMP:MGI.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:UniProtKB.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   CDD; cd01379; MYSc_Myo3; 1.
DR   Gene3D; 3.40.850.10; -; 1.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR036083; MYSc_Myo3.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00612; IQ; 1.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 2.
DR   SMART; SM00242; MYSc; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50096; IQ; 2.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Actin-binding; ATP-binding; Cell projection; Cytoplasm; Cytoskeleton;
KW   Hearing; Kinase; Motor protein; Myosin; Nucleotide-binding;
KW   Reference proteome; Repeat; Sensory transduction;
KW   Serine/threonine-protein kinase; Transferase; Vision.
FT   CHAIN           1..1613
FT                   /note="Myosin-IIIa"
FT                   /id="PRO_0000086414"
FT   DOMAIN          21..287
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          338..1052
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   DOMAIN          1054..1083
FT                   /note="IQ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          1081..1110
FT                   /note="IQ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   REGION          933..955
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   REGION          1136..1168
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1398..1476
FT                   /note="Interaction with MORN4"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NEV4"
FT   REGION          1476..1506
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1137..1162
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        150
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         27..35
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         50
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
SQ   SEQUENCE   1613 AA;  184730 MW;  19DFD980BF7B8847 CRC64;
     MLPLIGKTII FDNFPDPSDT WEIIETIGKG TYGKVFKVLN KKSGQKAAVK ILDPIHDIDE
     EIEAEYNILR TLSDHPNVVR FYGIYFKKDK INGDKLWLVL ELCNGGSVTD LVKGFLKRGE
     RMSEPVIAYI LHEALMGLQH LHSNKTIHRD VKGNNILLTT EGGVKLVDFG VSAQLSSTRH
     RLNTSVGTPF WMAPEVIACE QQLDTTYDAR CDTWSLGITA IELGDGDPPL AELHPMRALF
     KIPRNPPPKL RQPELWSAEF NDFISKCLTK DYEKRPTVSD LLKHKFITQI EGKDVILQKQ
     LMEFIDIHQC LGSTEKARHE RIHTKKGNLN RSLISSLKDV DDLATLDVLD EPTASPHLHP
     CHSRDQIHIH VADILIALNP FQSLGIYSPK LSRLYIGAKR TANPPHIFAM ADLGYQSMVT
     YNADQCIVIS GESGAGKTES AHLLVQQLTV LGKANNRTLQ EKILQMNNLV EAFGNACTII
     NDNSSRFGKY LEMKFTSSGA VVGAQISEYL LEKSRVIHQA MGEKNFHIFY YIYGGLAEKK
     KLALYKSPEH KPPRYLQNDN LRTVQDMMNN SFYKSQYELI EQCFKVIGFT MEQLASVYSV
     LAAILNVGNI EFSSVATEYQ MDKSYICNHT ALENCASLLC IQADELQEAL TSHCVVTRGE
     TIIRPNTVEK AADVRDAMAK TLYGRLFSCI VNCINSLLKH DTSPSGDEEL NIGILDIFGF
     ENFKRNSFEQ LCINIANEQI QYYFNQHVFA WEQNEYLNED VDARVIEYED NRPLLDMFLQ
     KPMGLLSLLD EESRFPKATD QTLIEKFEDN LKSQYFWRPK RMELSFGIHH YAGKVLYSAS
     GFLAKNRDTF PTDIVLPLRS SENSVIRQLV NHPLTKTGNL PLSKTKNIVN YQMWNSEKST
     NLTKGETRDV TCHACETTNV KTQTVSSYFR YSLMDLLSKM VVGQPHFVRC IKPNNERQAR
     KYDKEKVLLQ LRCTGILETA RIRRLGYSHR ILFANFIKRY YILCYKSSEE PPVSPDTCAA
     ILEKAGLDNW ALGKTKVFLK YYHVEQLNLM RKEATNKLVL IQASVRAFLG ARRYQELQQK
     RKSSAVIIQS AARGHLVRKQ RKEIVDMKNT AVTTIQTSDQ EFDYKKNFEN TRESFVKKQT
     ENAVPTNESN TSTPNNKESP SAGKTAPFIA ESKATNVESN NRRYHTQKKM SNVYAEGQNQ
     ELYIVEDTWA EVSPRQKYVQ DLEESRKMRK EEKGDAVIQS YCQWYTEGSN FEESKATCLE
     GRETWERTSC PGLWLTEEIY LRKTLDPTLS QKSVYQNADG KEKEHKVSVV TQNAPLGNLE
     RDYHLLGFLG EEDTGPVPQA QEEHKAVSIH SKYQSSKKKQ QLGKDRLAPP FKNQKILSSS
     TEVAKTTHNV YPCPTKQEGV HHSKMVDERD SKMASKKEAW DLAMFSRQIS KLSEEYFILQ
     KNLNEIILAQ QLKPFYLGIY RHKPINRHVS THQYLSGVSK GEEPKILRPP RRPRKPKTLN
     NPEDSTYYYL LHKSTQEEKR RPGKDSQGKL LGLEDFYYKE FLPTHYGPKA HSSNAREWKA
     LKEPQAQPIE SNERCWTTSE NESLEEERIS ANPYDYRRLL RKTSQRQRLV QQL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024